CCL2 and Behcet disease: IL-6 has been shown to be significantly up-regulated following BD and is hypothesized to be a key cytokine mediating the inflammatory cellular response to BD through an NF κB mediated pathway with the downstream effectors being selectin, MCP-1 and TNF- α[43].